01541.HK
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 3.15
−1.56%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.78x
- Price / sales
- 7.33x
- Price / cash flow
- -15.34x
Enterprise value
- Enterprise value
- HKD 614.0M
- EV / sales
- 3.46x
- EV / EBITDA
- -2.71x
- EV / EBIT
- -2.57x
- Market cap
- HKD 1.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026